Tempus ECG-AF vs TeraRecon Cardiac.Chambers.MR
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tempus ECG-AF is an AI tool focused on predicting the risk of atrial fibrillation using 12-lead ECGs, aiding in early identification for patients 65 or older. In contrast, TeraRecon Cardiac.Chambers.MR is an AI solution for automatic segmentation and volumetric analysis of cardiac chambers from MR images, supporting broader cardiac diagnosis and treatment planning. While both are cardiology AI tools, they address different clinical problems using distinct diagnostic modalities.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Tempus ECG-AF is a software solution designed to integrate into healthcare facility systems and existing ECG platforms and EHRs. It analyzes 12-lead ECG recordings from compatible GE Medical Systems and Philips Medical Systems to identify patients aged 65 or older at increased risk of developing AF within 12 months, supporting earlier identification and follow-up.
TeraRecon Cardiac.Chambers.MR automatically segments cardiac chambers from DICOM-compliant MR images, generating DICOM output files for interoperability with PACS and other systems. This automation provides volumetric analysis of ejection fraction, LV/RV inner and outer contour detection, and supports the AHA 17 segmentation model, enhancing diagnostic precision and treatment planning.
Tempus ECG-AF integrates into healthcare facility systems and is compatible with FDA-authorized 12-lead ECGs from GE Medical Systems and Philips Medical Systems, with solutions designed to work with existing ECG platforms and EHRs. TeraRecon Cardiac.Chambers.MR inputs DICOM-compliant MR images and outputs DICOM files, ensuring interoperability with PACS and other DICOM-compliant systems for seamless data exchange and archiving.
Tempus ECG-AF supports the earlier identification of patients aged 65 or older at increased risk of developing atrial fibrillation/flutter within 12 months, enabling timely follow-up and potential intervention. This proactive approach can lead to improved patient outcomes by addressing AF earlier.
The tool enhances precision by providing automatic segmentation of cardiac chambers, volumetric analysis of ejection fraction, and support for the AHA 17 segmentation model. These features offer objective and quantifiable data, aiding physicians in comprehensive diagnosis and treatment planning for cardiovascular conditions.
Tempus ECG-AF demonstrated a sensitivity of 31% and a specificity of 92% for classifying patients who developed clinically recognized AF within one year, with a negative predictive value of 95%. TeraRecon Cardiac.Chambers.MR provides automatic segmentation of cardiac chambers from MR images, offering consistent and objective volumetric analysis to aid diagnosis, though specific accuracy metrics were not provided in the initial description.
More Comparisons
Backers
Who funded each tool's parent company.